论文部分内容阅读
加入世界贸易组织以来,我国对于知识产权保护的相关法律、法规进一步完善,司法实践也取得了相当的经验。在知识产权案件中,专利纠纷案件所占的比重相当大,而且,由于专利纠纷案件往往与新技术结合在一起,成为知识产权案件中相对复杂的一部分。同时,笔者注意到,在专利纠纷案件之中,又属药品领域的专利纠纷案件最为复杂,这类案件往往既涉及药物专业知识,又受到国家药品审查政策的影响,更加值得去研究和思考。现以北京市某法院刚刚审结的一起药品专利纠纷案件为例,对药品专利纠纷所涉部分法律问题进行分析,供大家参考。
Since joining the WTO, our country has further improved the relevant laws and regulations on the protection of intellectual property and has gained considerable experience in judicial practice. In intellectual property cases, the proportion of patent disputes is quite large. Moreover, since patent dispute cases are often combined with new technologies, they have become a relatively complicated part of intellectual property cases. At the same time, the author noticed that in the case of patent disputes, patent disputes are the most complicated cases in the field of medicine. Such cases often involve both the professional knowledge of drugs and the influence of the national drug review policy, which is more worthy of study and reflection. Now with a court in Beijing just concluded a patent drug dispute cases, for example, the drug patent disputes part of the legal issues for your reference.